natgillin/translations-raw huggingface dataset:
Concerning Title IV of the EC Treaty which comprises the legal basis for judicial cooperation in civil matters, a special regime applies to Denmark, Ireland and the United Kingdom.
Kar zadeva naslov IV Pogodbe ES, ki je pravna podlaga za pravosodno sodelovanje v civilnih zadevah, se za Dansko, Irsko in Združeno kraljestvo uporablja posebna ureditev.
Measures taken under Title IV of the EC Treaty are not binding upon or applicable in Denmark.
Ukrepi, sprejeti na podlagi naslova IV Pogodbe ES, za Dansko niso zavezujoči in se za njo ne uporabljajo.
Ireland and the United Kingdom take part in legal instruments adopted under Title IV of the EC Treaty if they notify the Council to that effect.
Irska in Združeno kraljestvo sodelujeta pri pravnih instrumentih, sprejetih na podlagi naslova IV Pogodbe ES, če o tem uradno obvestita Svet.
Ireland and the United Kingdom have decided to opt in on all measures listed at point 5 above.
Irska in Združeno kraljestvo sta se odločila, da bosta sodelovala pri vseh ukrepih iz točke 5.
The extent of competence which the Member States have transferred to the European Community pursuant to the EC Treaty is, by its nature, liable to continuous development.
Obseg pristojnosti, ki so jih države članice prenesle na Evropsko skupnost v skladu s Pogodbo ES, je že zaradi svojega značaja stvar nenehnega razvoja.
The European Community and its Member States will ensure that any change in the Community's competences will be promptly notified to the Secretary-General of the HCCH as stipulated in Article 2A(4) of the Statute.
Evropska skupnost in njene države članice bodo poskrbele, da bo generalni sekretar HCCH nemudoma obveščen o vseh spremembah pristojnosti Skupnosti, kakor določa člen 2A(4) statuta.
Opinion 1/76 of the Court of Justice, ECR 1977, p. 741; Opinion 2/91, ECR 1993, p. I-1061; Case 22/70 (AETR); Commission v Council, ECR 1971, p. 263; Case-C-467/98 (open skies), Commission v Denmark, ECR 2002, p. I-9519.
Mnenje Sodišča 1/76, ZOdl. 1977, str. 741; Mnenje 2/91, ZOdl. 1993, str. I-1061; Zadeva 22/70 („AETR“); Komisija proti Svetu, ZOdl. 1971, str. 263; Zadeva C-467/98 ( „open skies“), Komisija proti Danski, ZOdl. 2002, str. I-9519.
Case 22/70 (‘AETR’), Commission v Council, Case-C-467/98 ( ‘open skie’), Commission v. Denmark.
Zadeva 22/70 („AETR“), Komisija proti Svetu, Zadeva C-467/98 ( „open skies“), Komisija proti Danski.
Declaration by the Community on certain matters concerning the Hague Conference on Private International law
Izjava Evropske skupnosti o določenih zadevah, ki se nanašajo na Haško konferenco o mednarodnem zasebnem pravu
The European Community endeavours to examine whether it is in its interest to join existing Hague Conventions in respect of which there is Community competence.
Evropska skupnost si prizadeva proučiti, ali je v njenem interesu, da se pridruži obstoječim haaškim konvencijam, ki spadajo v področje njene pristojnosti.
Where this interest exists, the European Community, in cooperation with the HCCH, will make every effort to overcome the difficulties resulting from the absence of a clause providing for the accession of a Regional Economic Integration Organisation to those Conventions.
Če ta interes obstaja, bo Evropska skupnost v sodelovanju s HCCH storila vse, da bi premagala težave, ki izhajajo iz dejstva, da ni klavzule, ki bi predvidevala pristop organizacije za regionalno gospodarsko povezovanje k tem konvencijam.
The European Community further endeavours to make it possible for representatives of the Permanent Bureau of the HCCH to take part in meetings of experts organised by the Commission of the European Communities where matters of interest to the HCCH are being discussed.
Nadalje si Evropska skupnost prizadeva, da bi predstavnikom Stalnega urada HCCH omogočila sodelovanje na sejah strokovnjakov, ki jih organizira Evropska komisija, kjer se razpravlja o zadevah, ki so v interesu HCCH.
The European Community formally and without reservation accepts the obligations arising from its membership of the Hague Conference on Private International Law, as set out in the Statute, and formally undertakes to fulfil the obligations upon it at the time of its accession.
Evropska skupnost formalno in brez pridržka sprejema obveznosti, ki izhajajo iz njenega članstva pri Haaški konferenci o mednarodnem zasebnem pravu, kot je določeno v statutu, ter se formalno zavezuje, da bo ob svojem pristopu izpolnjevala svoje obveznosti.
I have the honour to be, Sir, yours faithfully,
S spoštovanjem,
authorising the placing on the market of diacylglycerol oil of plant origin as a novel food under Regulation (EC) No 258/97 of the European Parliament and of the Council
o odobritvi dajanja v promet diacilglicerolnega olja rastlinskega izvora kot novega živila v skladu z Uredbo (ES) št. 258/97 Evropskega parlamenta in Sveta
(notified under document number C(2006) 4971)
(notificirano pod dokumentarno številko C(2006) 4971)
Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 [1], and in particular Article 7 thereof,
ob upoštevanju Uredbe (ES) št. 258/97 Evropskega parlamenta in Sveta z dne 27. januarja 1997 [1] in zlasti člena 7 Uredbe,
On 17 April 2002 Archer Daniels Midland Company (hereafter ‘ADM’) made a request to the competent authorities of the Netherlands to place diacylglycerol oil of plant origin on the market as a novel food for use in cooking oils, fat spreads, salad dressings, mayonnaise, drinks presented as a replacement for one or more meals of the daily diet, bakery products and yoghurt type products.
aprila 2002 je družba Archer Daniels Midland Company (v nadaljnjem besedilu „ADM“) vložila pri pristojnih nizozemskih organih zahtevek za odobritev dajanja v promet diacilglicerolnega olja rastlinskega izvora kot novega živila za uporabo v oljih za kuhanje, maščobnih namazih, solatnih prelivih, majonezah, pijačah, ki so nadomestilo za en obrok ali več dnevnih obrokov dnevno zaužite hrane, pekarskih proizvodih in izdelkih iz jogurta.
On 20 December 2002 the competent authorities of the Netherlands issued their initial assessment report.
decembra 2002 so pristojni nizozemski organi izdali poročilo o začetni presoji.
In that report they came to the conclusion that the use of diacylglycerol oil of plant origin is safe for human consumption.
V navedenem poročilu so ugotovili, da je diacilglicerolno olje rastlinskega izvora varno za prehrano ljudi.
The Commission forwarded the initial assessment report to all Member States on 21 January 2003.
Komisija je poslala začetno poročilo o začetni presoji vsem državam članicam 21. januarja 2003.
Within the 60 day period laid down in Article 6(4) of Regulation (EC) No 258/97, reasoned objections to the marketing of the product were raised in accordance with that provision.
V roku šestdesetih dni, kot je določeno v členu 6(4) Uredbe (ES) št. 258/97, so bili skladno z navedeno določbo izraženi obrazloženi ugovori glede trženja tega proizvoda.
The European Food Safety Authority (EFSA), in its opinion on an application from ADM for approval of diacylglycerol oil (EnovaTM oil) of 2 December 2004 [2], came to the conclusion that the oil is safe for human consumption.
Evropska agencija za varnost hrane (EFSA) je v svojem mnenju o zahtevku ADM za odobritev diacilglicerolnega olja (olja EnovaTM) z dne 2. decembra 2004 [2] ugotovila, da je olje varno za prehrano ljudi.
With respect to the content of trans fatty acids EFSA recommended that it should be reduced to the level in the conventional oils of plant origin that the novel oil is intended to replace, in order for the oil not to be nutritionally disadvantageous to the consumer.
Da olje ne bi bilo neustrezno za prehrano potrošnikov, je EFSA glede vsebnosti transmaščobnih kislin priporočila njeno zmanjšanje na raven, kot je v konvencionalnih oljih rastlinskega izvora, ki naj bi jih novo olje nadomestilo.
As regards drinks presented as a replacement for one or more meals of the daily diet Council Directive 89/398/EEC of 3 May 1989 on the approximation of laws of the Member States relating to foodstuffs intended for particular nutritional uses [3] applies.
Glede pijač, ki so nadomestilo za enega ali več obrokov, velja Direktiva Sveta 89/398/EGS z dne 3. maja 1989 o približevanju zakonodaje držav članic, ki se nanaša na živila za posebne prehranske namene [3].
Diacylglycerol oil of plant origin as specified in the Annex, may be placed on the market in the Community as a novel food for use in cooking oils, fat spreads, salad dressings, mayonnaise, drinks presented as a replacement for one or more meals of the daily diet, bakery products and yoghurt type products.
Diacilglicerolno olje rastlinskega izvora, kot je opredeljeno v Prilogi, se lahko da v promet v Skupnosti kot novo živilo za uporabo v oljih za kuhanje, maščobnih namazih, solatnih prelivih, majonezah, pijačah, ki so nadomestilo za en obrok ali več dnevnih obrokov dnevno zaužite hrane, pekarskih proizvodih in proizvodih iz jogurta.
The designation ‘diacylglycerol oil of plant origin (at least 80 % diacylglycerols)’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.
Poimenovanje „diacilglicerolno olje rastlinskega izvora (najmanj 80 % diacilglicerola)“ se navede na embalaži proizvoda ali seznamu sestavin živil, ki olje vsebujejo.
This Decision is addressed to ADM Kao LLC, 4666 East Faries Parkway, Decatur, IL 62526, USA
Ta odločba je naslovljena na ADM Kao LLC, 4666 East Faries Parkway, Decatur, IL 62526, ZDA
Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to an application to market Enova oil as a novel food in the EU of 2.12.2004.
Mnenje Znanstvenega odbora za dietetične izdelke, prehrano in alergije na zahtevo Komisije, v zvezi z zahtevkom za odobritev dajanja v promet olja Enova kot novega živila v EU z dne 2.12.2004.
The opinion can be found on the website of the European Food Safety Authority, Scientific Panel on Dietetic Products, Nutrition and Allergies.
Mnenje je na voljo na spletni strani Evropske agencije za varnost hrane Znanstvenega odbora za dietetične izdelke, prehrano in alergije.
Directive as last amended by Directive 1999/41/EC of the European Parliament and of the Council (OJ L 172, 8.7.1999, p. 38).
Direktiva, kakor je bila nazadnje spremenjena z Direktivo 1999/41/ES Evropskega parlamenta in Sveta (UL L 172, 8.7.1999, str. 38).
SPECIFICATION OF DIACYLGLYCEROL OIL OF PLANT ORIGIN
SESTAVA DIACILGLICEROLNEGA OLJA RASTLINSKEGA IZVORA
MAG = monoacylglycerols, DAG = diacylglycerols, TAG = triacylglycerols
MAG monoacilgliceroli, DAG diacilgliceroli, TAG triacilgliceroli
Fatty acid components are derived from edible vegetable oils, in particular from soybean oil (Glycine max) or rapseed oil (Brassica campestris, Brassica napus).
Sestavni deli maščobnih kislin so pridobljeni iz užitnih rastlinskih olj, zlasti iz sojinega olja (Glicine max) ali repičnega olja (Brassica campestris, Brassica napus).
Substance/Parameter
Snov/parameter
Content
Vsebnost
Acylglycerol Distribution:
Porazdelitev acilglicerola:
Diacylglycerols (DAG)
diacilgliceroli (DAG)
Not less than 80 %
ne manj kot 80 %
1,3-Diacylglycerols (1,3-DAG)
1,3-diacilgliceroli
Not less than 50 %
ne manj kot 50 %
Triacylglycerols (TAG)
triacilgliceroli (TAG)
Not more than 20 %
ne več kot 20 %
Monoacylglycerols (MAG)
monoacilgliceroli (MAG)
Not more than 5 %
ne več kot 5 %
Fatty Acid Composition (MAG, DAG, TAG):
Sestava maščobnih kislin (MAG, DAG, TAG):
Oleic acid (C18:1)
oleinska kislina (C18:1)
Between 20 and 65 %
med 20 in 65 %
Linoleic acid (C18:2)
linolejska kislina (C18:2)
Between 15 and 65 %
med 15 in 65 %
Linolenic acid (C18:3)
linolenska kislina (C18:3)
Not more than 15 %
ne več kot 15 %
Saturated fatty acids
Proste maščobne kisline
Not more than 10 %
ne več kot 10 %
Others:
Drugo:
Acid value
kislinska vrednost
Not more than 0,5 mg KOH/g
ne več kot 0,5 mg KOH/g
Moisture and volatile
vlaga in hlapnost
Not more than 0,1 %
ne več kot 0,1 %
Peroxide value (PV)
peroksidna vrednost (PV)
Not more than 1 meq/kg
ne več kot 1 meq/kg
Unsaponifiables
snovi, ki jih ni mogoče saponificirati
Not more than 2 %
ne več kot 2 %
Trans fatty acids
transmaščobne kisline
Not more than 1 %
ne več kot 1 %
authorising the placing on the market of lycopene from Blakeslea trispora as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
o odobritvi dajanja v promet likopena iz gliv Blakeslea trispora kot nove živilske sestavine v skladu z Uredbo (ES) št. 258/97 Evropskega parlamenta in Sveta
(notified under document number C(2006) 4973)
(notificirano pod dokumentarno številko C(2006) 4973)
Having regard to the Treaty establishing the Europeån Community,
ob upoštevanju Pogodbe o ustanovitvi Evropske skupnosti,
Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients [1], and in particular Article 7 thereof,
ob upoštevanju Uredbe (ES) št. 258/97 Evropskega parlamenta in Sveta z dne 27. januarja 1997 v zvezi z novimi živili in novimi živilskimi sestavinami [1] ter zlasti člena 7 Uredbe,
On 30 October 2003 Vitatene Antibiotics SAU made a request to the competent authorities of the United Kingdom to place lycopene from Blakeslea trispora on the market as a novel food or novel food ingredient.
Dne 30. oktobra 2003 je družba Vitatene Antibiotics SAU pri pristojnih organih Združenega kraljestva vložila zahtevek za dajanje v promet likopena iz Blakeslea trispora kot novega živila ali nove živilske sestavine.
On 6 April 2004 the competent food assessment body of the United Kingdom issued its initial assessment report.
Dne 6. aprila 2004 je pristojni organ Združenega kraljestva za ocenjevanje živil izdal začetno poročilo o oceni.
In that report it came to the conclusion that the proposed uses for lycopene from Blakeslea trispora are safe for human consumption.
V tem poročilu je prišel do ugotovitve, da so priporočene rabe likopena iz Blakeslea trispora varne za prehrano ljudi.
The Commission forwarded the initial assessment report to all Member States on 27 April 2004.
Komisija je 27. aprila 2004 vsem državam članicam poslala začetno poročilo o oceni.
Within the 60-day period laid down in Article 6(4) of Regulation (EC) No 258/97 reasoned objections to the marketing of the product were raised in accordance with that provision.
V 60 dneh, kot je določeno v členu 6(4) Uredbe (ES) št. 258/97, so bili skladno z navedeno določbo podani obrazloženi ugovori glede trženja tega proizvoda.
Consequently, the European Food Safety Authority (EFSA) was consulted on 22 November 2004.
Zato je bil 22. novembra 2004 opravljen posvet z Evropsko agencijo za varnost hrane (EFSA).
On 21 April 2005 EFSA adopted the ‘Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to an application on the use of α-tocopherol-containing oil suspension of lycopene from Blakeslea trispora as a novel food ingredient’.
EFSA je 21. aprila 2005 sprejela „Mnenje Znanstvenega odbora za dietetične izdelke, prehrano in alergije na zahtevo Komisije o zahtevku za odobritev uporabe oljne suspenzije likopena z α-tokoferolom iz Blakeslea trispora kot nove živilske sestavine“.
The opinion came to the conclusion that the requested levels of use of lycopene from Blakeslea trispora would lead to an additional intake of up to about 2 mg/day.
Sklepna ugotovitev mnenja je, da bi zahtevan obseg uporabe likopena iz Blakeslea trispora povzročil dodaten vnos do približno 2 mg/dnevno.
It also concluded that this additional intake was not of concern from the safety point of view.
Poleg tega je bilo v mnenju ugotovljeno, da ta dodaten vnos ne pomeni tveganja glede varnosti.
Food additives falling within the scope of Council Directive 89/107/EEC of 21 December 1988 on the approximation of laws of the Member States concerning food additives authorised for use in foodstuffs intended for human consumption [2], are excluded from the scope of Regulation (EC) No 258/97.
Aditivi za živila s področja uporabe Direktive Sveta 89/107/EGS z dne 21. decembra 1988 o približevanju zakonodaj držav članic o aditivih za živila, ki se smejo uporabljati v živilih, namenjenih za prehrano ljudi [2], so izključeni iz področja uporabe Uredbe (ES) št. 258/97.
This Decision does therefore not constitute authorisation to use lycopene from Blakeslea trispora as a food colour.
Ta odločba torej ne dovoljuje uporabe likopena iz Blakeslea trispora kot živilskega barvila.
On the basis of the scientific assessment, it is established that lycopene from Blakeslea trispora in an α-tocopherol containing suspension complies with the criteria laid down in Article 3(1) of Regulation (EC) No 258/97.
Na podlagi začetnega poročila o oceni se ugotovi, da likopen iz Blakeslea trispora v suspenziji, ki vsebuje α-tokoferol, izpolnjuje merila iz člena 3(1) Uredbe (ES) št. 258/97.
Lycopene from Blakeslea trispora as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for use in foods as specified in Annex II.
Likopen iz Blakeslea trispora, kot je opredeljen v Prilogi I, se lahko da v promet v Skupnosti kot nova živilska sestavina za uporabo v živilih, kot je določeno v Prilogi II.
The designation ‘lycopene’ shall be displayed in the list of ingredients of foodstuffs containing it or, if there is no list of ingredients, on the labelling of the product as such.
Poimenovanje „likopen“ se navede na seznamu sestavin živil, ki vsebujejo likopen; če ni seznama sestavin, pa na oznaki proizvoda kot takega.
Vitatene Antibiotics SAU shall submit to the Commission, at the end of three years following the adoption of this Decision, data as to the groups of foods with lycopene from Blakeslea trispora that have been placed on the market in the EU and the corresponding use levels of this lycopene.
Ob koncu triletnega obdobja po sprejetju te odločbe družba Vitatene Antibiotics SAU Komisiji predloži podatke o skupinah živil z likopenom iz Blakeslea trispora, ki so bila dana v promet v EU, in primeren obseg uporabe tega likopena.
This Decision is addressed to Vitatene Antibiotics SAU, Avd. de Antibioticos, 59-61, 24080 Leon, Spain
Ta odločba je naslovljena na družbo Vitatene Antibiotics SAU, Avd. de Antibioticos, 59-61, 24080 Leon, Španija
Regulation as last amended by Regulation (EC) No 1882/2003 of the European Parliament and of the Council (OJ L 284, 31.10.2003, p. 1).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 1882/2003 Europskega parlamenta in Sveta (UL L 284, 31.10.2003, str. 1).
OJ L 40, 11.2.1989, p. 27.
UL L 40, 11.2.1989, str. 27.
SPECIFICATIONS OF LYCOPENE FROM BLAKESLEA TRISPORA
UPORABA LIKOPENA IZ BLAKESLEA TRISPORA
Obtained by extraction and crystallisation from a fungal fermentation of Blakeslea trispora, the product is supplied as a 5 % or 20 % lycopene suspension in high oleic acid sunflower oil containing 1 % α-tocopherol of the lycopene level.
Proizvod, pridobljen z ekstrakcijo in kristalizacijo iz glivičnega vrenja Blakeslea trispora, se dobavlja kot 5- ali 20-odstotna suspenzija likopena v sončničnem olju z visoko vrednostjo oleinske kisline, ki vsebuje 1 % α-tokoferola v likopenu.
The lycopene from Blakeslea trispora consists of ≥ 90 % all-trans isomer and 1 % to 5 % of cis-isomeres.
Likopen iz Blakeslea trispora vsebuje ≥ 90 % v celoti trans-izomerov in 1 do 5 % cis-izomerov. Specifikacije
Specifications
Kemijski naziv likopen
Chemical name Lycopene
Število C.A.S.
number 502-65-8 (all trans lycopene)
502-65-8 (v celoti trans-likopen)
Chemical formula C40H56
Kemijska formula C40H56
Formula weight 536,85
Molska masa 536,85
Assay Not less than 95 %
Molekulska masa ne manj kot 95 %
Purity Imidazole Not more than 1 mg/kg
Čistost Imidazol največ 1 mg/kg
Sulfated ash Not more than 1 %
Sulfatirani pepel največ 1 %
Other Carotenoids Not more than 5 %
Drugi karotenoidi največ 5 %
Mycotxins:
Mikotoksini:
Aflatoxin B1 Absent
Aflatoksin B1 ga ni
Trichothecene (T2) Absent
Trihotecin (T2) ga ni
Ochratoxin Absent
Okratoksin ga ni
Zearaleone Absent
Zearaleon ga ni
Moulds Not more than 100/g
Plesni največ 100/g
Yeasts Not more than 100/g
Kvasovke največ 100/g
Salmonella Absent in 25 g
Salmonela v 25 g je ni
Absent in 5 g
v 5 g je ni
USES OF LYCOPENE FROM BLAKESLEA TRISPORA
UPORABA LIKOPENA IZ BLAKESLEA TRISPORA
Use group
Skupina uporabe
Maximum level of lycopene
Največje dovoljene vsebnosti likopena:
Yellow fat spreads
Rumeni maščobni namazi
Milk based and milk type products
Izdelki na osnovi mleka in mlečni izdelki
Condiments, seasonings, relishes, pickles
Začimbe, kombinirane začimbe, pikantni dodatki k hrani, vložena zelenjava
Savoury sauces and gravies
Začinjene omake in omake iz mesnega soka
Soups and soup mixes
Juhe in mešanice za juhe
Sugar, preserves, confectionery
Sladkor, marmelade, džemi, sladkarije
of 24 October 2006
z dne 24. oktobra 2006
authorising the placing on the market of ‘rapeseed oil high in unsaponifiable matter’ as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
o odobritvi dajanja v promet „repičnega olja z visoko vsebnostjo neumiljive snovi“ kot nove živilske sestavine v skladu z Uredbo (ES) št. 258/97 Evropskega parlamenta in Sveta
(notified under document number C(2006) 4975)
(notificirano pod dokumentarno številko C(2006) 4975)
On 24 October 2001 the company Laboratoires Pharmascience (now Laboratoires Expanscience) made a request to the competent authorities of France to place ‘rapeseed oil high in unsaponifiable matter’ on the market as a novel food ingredient.
Dne 24. oktobra 2001 je družba Laboratoires Pharmascience (zdaj Laboratoires Expanscience) pri pristojnih organih Francije vložila zahtevek za dajanje v promet „repičnega olja z visoko vsebnostjo neumiljive snovi“ kot nove živilske sestavine.
On 8 January 2002 the competent authorities of France forwarded their initial assessment report to the Commission.
Dne 8. januarja 2002 je pristojni organ Francije Komisiji poslal začetno poročilo o oceni.
The report came to the conclusion that ‘rapeseed oil high in unsaponifiable matter’ proposed as a food ingredient at a daily intake of 1,5 g per day would make it possible to supplement vitamin E intake and also concluded that the levels of phytosterol were not sufficient to reduce cholesterolaemia.
Sklepna ugotovitev poročila je, da bi „repično olje z visoko vsebnostjo neumiljive snovi“, ki je predlagana kot živilska sestavina, ob dnevnem vnosu 1,5 g lahko dopolnjevalo vnos vitamina E ter da ravni fitosterola ne zadostujejo za zmanjšanje holesterolemije.
The Commission forwarded the initial assessment report to all Member States on 18 February 2002.
Komisija je 18. februarja 2002 vsem državam članicam poslala poročilo o začetni presoji.
Within the 60-day period laid down in Article 6(4) of Regulation (EC) No 258/97, reasoned objections to the marketing of the product were raised in accordance with that provision.
Kot je določeno v členu 6(4) Uredbe (ES) št. 258/97, so bili v 60 dneh podani obrazloženi ugovori glede trženja tega proizvoda v skladu z navedeno določbo.
The European Food Safety Authority (EFSA) was therefore consulted on 30 January 2004.
Zato je bil 30. januarja 2004 opravljen posvet z Evropsko agencijo za varnost hrane (EFSA).
On 6 December 2005, EFSA adopted the ‘Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to “rapeseed oil high in unsaponifiable matter” as a novel food ingredient’.
EFSA je 6. decembra 2005 sprejela „Mnenje Znanstvenega odbora za dietetične izdelke, prehrano in alergije na zahtevo Komisije v zvezi z ‚,repičnim oljem z visoko vsebnostjo neumiljive snovi‘ kot nove živilske sestavine“.
The opinion came to the conclusion that the proposed use level of 1,5 g per day of ‘rapeseed oil high in unsaponifiable matter’ was safe.
Sklepna ugotovitev mnenja je, da je predlagan vnos 1,5 g dnevno „repičnega olja z visoko vsebnostjo neumiljive snovi“ varen.